Hematology
DIC Laboratory Interpretation
Interpret suspected disseminated intravascular coagulation by integrating a triggering disorder with serial platelet count, PT, fibrinogen, and fibrin-related markers; use a validated score to identify overt disease while actively excluding mimics that require fundamentally different treatment.
Initial assessment
Order a focused serial coagulation panel when a DIC trigger is present
Testing is most informative when laboratory abnormalities are interpreted in clinical context.
Obtain a platelet count, PT or INR, fibrinogen, and a fibrin-related marker (D-dimer or FDP) when a patient has a plausible DIC trigger plus bleeding, thrombosis, shock, organ dysfunction, or otherwise unexplained evolving coagulopathy. DIC is most often associated with acute infection or sepsis, but shock, obstetric disorders, malignancy, vascular injury, trauma, toxic or immunologic reactions, and organ injury are recognized triggers. BMJ+2BMJDisseminated intravascular coagulation - Symptoms, diagnosis and treatment | BMJ Best Practice USWolters KluwerDisseminated Intravascular Coagulation Syndromes... : Obstetrics & GynecologyScienceDirectDisseminated Intravascular Coagulation - an overview | ScienceDirect Topics
Repeat the same panel when DIC remains clinically suspected because trajectory is diagnostic: a falling platelet count, progressively prolonged PT, declining fibrinogen, or increasing fibrin-related markers provides more useful evidence of ongoing consumption than a single isolated abnormality. Formal DIC systems are based on global coagulation tests and include platelet count, PT, fibrinogen, and fibrin-related markers. Wiley+1WileyA re‐evaluation of the D‐dimer cut‐off value for making a diagnosis according to the ISTH overt‐DIC diagnostic criteria: communication from the SSC of the ISTH - Suzuki - 2018 - Journal of Thrombosis and Haemostasis - Wiley Online LibraryPubMedDiagnosis of sepsis‐induced disseminated intravascular coagulation and coagulopathy - PMC
Interpret each result against preexisting disease and treatment exposures. Liver failure can produce thrombocytopenia, prolonged PT, and reduced fibrinogen without proving DIC; the Japanese Society on Thrombosis and Hemostasis infection score specifically applies a negative adjustment for liver failure. Anticoagulant exposure and laboratory-specific reference limits likewise require interpretation before assigning causality to DIC. PubMedPubMedDiagnosis of sepsis‐induced disseminated intravascular coagulation and coagulopathy - PMC
Use a compatible underlying disorder as the entry criterion for formal DIC scoring. ScienceDirect+1ScienceDirectDisseminated Intravascular Coagulation - an overview | ScienceDirect TopicsPubMedDiagnosis of sepsis‐induced disseminated intravascular coagulation and coagulopathy - PMC
Review the platelet trend, not just the absolute count; several systems credit a decline of 30% or more within 24 hours or 50% or more within 24 hours. PubMedPubMedDiagnosis of sepsis‐induced disseminated intravascular coagulation and coagulopathy - PMC
Document whether D-dimer is reported in fibrinogen-equivalent units or fibrin units before applying any numeric threshold. WileyWileyA re‐evaluation of the D‐dimer cut‐off value for making a diagnosis according to the ISTH overt‐DIC diagnostic criteria: communication from the SSC of the ISTH - Suzuki - 2018 - Journal of Thrombosis and Haemostasis - Wiley Online Library
Diagnostic scoring
Calculate the ISTH overt-DIC score from the complete panel
Use the score to standardize interpretation rather than to replace clinical judgment.
For a patient with an underlying disorder known to be associated with DIC, assign ISTH points for platelet count, fibrin-related marker elevation, PT prolongation, and fibrinogen. A total score of 5 or greater meets the ISTH overt-DIC threshold. ScienceDirect+1ScienceDirectDisseminated Intravascular Coagulation - an overview | ScienceDirect TopicsPubMedDiagnosis of sepsis‐induced disseminated intravascular coagulation and coagulopathy - PMC
The score is designed to integrate consumption and fibrin turnover. A markedly elevated D-dimer without thrombocytopenia or PT prolongation is not equivalent to overt DIC, and thrombocytopenia with normal fibrin-related markers should prompt a parallel search for non-DIC causes. ScienceDirect+1ScienceDirectDisseminated Intravascular Coagulation - an overview | ScienceDirect TopicsPubMedDiagnosis of sepsis‐induced disseminated intravascular coagulation and coagulopathy - PMC
Do not transfer numeric D-dimer cutoffs between laboratories. In a comparison of six assays, the cutoffs corresponding to ISTH point assignments differed by assay and by fibrinogen-unit versus fibrin-unit reporting; the investigators proposed D-dimer values above 3.0 μg/mL for 2 points and above 7.0 μg/mL for 3 points in the studied context. Local laboratory validation remains necessary. WileyWileyA re‐evaluation of the D‐dimer cut‐off value for making a diagnosis according to the ISTH overt‐DIC diagnostic criteria: communication from the SSC of the ISTH - Suzuki - 2018 - Journal of Thrombosis and Haemostasis - Wiley Online Library
Sepsis branch
Use SIC criteria for early sepsis-associated coagulopathy
Sepsis requires a distinct interpretation because early fibrinogen and D-dimer changes may be less discriminating.
In a patient meeting Sepsis-3 criteria, calculate the sepsis-induced coagulopathy (SIC) score using SOFA score, platelet count, and PT ratio. SIC requires infection with organ dysfunction and a total score of 4 or greater; the system does not include fibrinogen or fibrin-related markers. Wiley+1WileyDiagnosis of sepsis‐induced disseminated intravascular ...PubMedDiagnosis of sepsis‐induced disseminated intravascular coagulation and coagulopathy - PMC
For SIC, assign SOFA 1 point for a score of 1 and 2 points for a score of 2 or greater; assign platelet 1 point for 100 to less than 150 × 10^9/L and 2 points for less than 100 × 10^9/L; assign PT ratio 1 point for greater than 1.2 to 1.4 and 2 points for greater than 1.4. PubMedPubMedDiagnosis of sepsis‐induced disseminated intravascular coagulation and coagulopathy - PMC
When SIC is present, continue serial platelet count and PT monitoring and calculate the ISTH overt-DIC score if the coagulation phenotype progresses. The clinical priority remains prompt control of sepsis and associated organ dysfunction, because acute infection and sepsis are the most common DIC-associated disorders. BMJ+2BMJDisseminated intravascular coagulation - Symptoms, diagnosis and treatment | BMJ Best Practice USWileyDiagnosis of sepsis‐induced disseminated intravascular ...PubMedDiagnosis of sepsis‐induced disseminated intravascular coagulation and coagulopathy - PMC
SIC is applicable only in sepsis with organ dysfunction; do not use it for obstetric hemorrhage, trauma, malignancy, or vascular injury. Wiley+1WileyDiagnosis of sepsis‐induced disseminated intravascular ...PubMedDiagnosis of sepsis‐induced disseminated intravascular coagulation and coagulopathy - PMC
A platelet count of 100 to less than 150 × 10^9/L can contribute to SIC even though it earns no platelet point in the ISTH overt-DIC system. PubMedPubMedDiagnosis of sepsis‐induced disseminated intravascular coagulation and coagulopathy - PMC
Fibrinogen and D-dimer remain clinically informative but are not SIC score components. Wiley+1WileyDiagnosis of sepsis‐induced disseminated intravascular ...PubMedDiagnosis of sepsis‐induced disseminated intravascular coagulation and coagulopathy - PMC
Diagnostic pitfalls
Separate DIC from thrombotic microangiopathy and nonconsumptive coagulopathy
The combination of tests, rather than thrombocytopenia alone, determines the next diagnostic branch.
DIC usually produces a global consumptive pattern: thrombocytopenia, prolonged PT and often aPTT or thrombin time, elevated fibrinogen/fibrin degradation products, and reduced fibrinogen; antithrombin and protein C may also be low. This pattern is most persuasive when it evolves alongside a recognized trigger. ScienceDirectScienceDirectDisseminated Intravascular Coagulation - an overview | ScienceDirect Topics
Thrombotic thrombocytopenic purpura and other thrombotic microangiopathies may overlap clinically through thrombocytopenia and microvascular injury, but schistocytes are generally more numerous in TTP than in DIC. A smear with substantial schistocytosis should therefore prevent reflex labeling of all thrombocytopenia as DIC and trigger an urgent thrombotic-microangiopathy evaluation. ScienceDirectScienceDirectDisseminated Intravascular Coagulation - an overview | ScienceDirect Topics
In hepatic dysfunction, prolonged PT, thrombocytopenia, and low fibrinogen can mimic DIC. Interpret fibrin-related marker change, clinical trigger, serial deterioration, and scoring results together; the JSTH infection-oriented framework explicitly recognizes liver failure as a confounder. PubMedPubMedDiagnosis of sepsis‐induced disseminated intravascular coagulation and coagulopathy - PMC
Do not use thromboelastography as a substitute for the platelet count, PT, fibrinogen, and fibrin-related marker panel to confirm laboratory DIC; it may instead help monitor global hemostasis during blood-component management. ScienceDirectScienceDirectDisseminated Intravascular Coagulation - an overview | ScienceDirect Topics
A fibrin-related marker result should support, not independently establish, DIC because elevation is assay dependent and occurs in many acute illnesses. Wiley+1WileyA re‐evaluation of the D‐dimer cut‐off value for making a diagnosis according to the ISTH overt‐DIC diagnostic criteria: communication from the SSC of the ISTH - Suzuki - 2018 - Journal of Thrombosis and Haemostasis - Wiley Online LibraryScienceDirectDisseminated Intravascular Coagulation - an overview | ScienceDirect Topics
When bleeding and thrombosis coexist with compatible serial laboratory change, prioritize DIC over isolated thrombocytopenic disorders. ScienceDirectScienceDirectDisseminated Intravascular Coagulation - an overview | ScienceDirect Topics
Clinical action
Escalate management when the laboratory pattern indicates active consumption
Laboratory confirmation should accelerate source control and hemorrhage management, not delay them.
Once serial results support DIC, identify and treat the driver immediately. In obstetric DIC, management requires prompt recognition and treatment of both the underlying disorder and associated hemorrhage. In other settings, sepsis, shock, malignancy, trauma, vascular injury, or toxic or immunologic injury should direct the definitive intervention. BMJ+1BMJDisseminated intravascular coagulation - Symptoms, diagnosis and treatment | BMJ Best Practice USWolters KluwerDisseminated Intravascular Coagulation Syndromes... : Obstetrics & Gynecology
Use blood-component therapy to address clinically important bleeding or procedure-related hemostatic need rather than treating a score alone. Fresh frozen plasma, platelets, cryoprecipitate, and whole blood are commonly used first-line products in global DIC practice, but selection must be matched to the deficient component and the active bleeding context. ScienceDirectScienceDirectGlobal practice and challenges in the diagnosis and management of disseminated intravascular coagulation: communication from the ISTH SSC Subcommittee on Disseminated Intravascular Coagulation - ScienceDirect
Continue serial platelet count, PT, fibrinogen, and fibrin-related marker testing while active DIC is suspected. Improvement in the underlying disorder should be accompanied by stabilization of platelet count and PT and reduced evidence of ongoing consumption; worsening results require reassessment for uncontrolled source, recurrent hemorrhage, thrombosis, or an alternative diagnosis. BMJ+2BMJDisseminated intravascular coagulation - Symptoms, diagnosis and treatment | BMJ Best Practice USScienceDirectDisseminated Intravascular Coagulation - an overview | ScienceDirect TopicsPubMedDiagnosis of sepsis‐induced disseminated intravascular coagulation and coagulopathy - PMC
Escalate urgently for bleeding at minimally traumatized sites, shock, or progressive organ dysfunction in a patient with a DIC-compatible laboratory pattern. Wolters Kluwer+1Wolters KluwerDisseminated Intravascular Coagulation Syndromes... : Obstetrics & GynecologyScienceDirectDisseminated Intravascular Coagulation - an overview | ScienceDirect Topics
In pregnancy-associated DIC, prioritize the obstetric cause and hemorrhage simultaneously; obstetric DIC contributes substantially to maternal morbidity and mortality. Wolters KluwerWolters KluwerDisseminated Intravascular Coagulation Syndromes... : Obstetrics & Gynecology
Do not use a single normalized or preserved fibrinogen value to terminate surveillance when platelets and PT are worsening. PubMedPubMedDiagnosis of sepsis‐induced disseminated intravascular coagulation and coagulopathy - PMC
References
- Disseminated intravascular coagulation - Symptoms, diagnosis and treatment | BMJ Best Practice US — bestpractice.bmj.com · bestpractice.bmj.com
- Exploring the epidemiology of disseminated intravascular coagulation — bmjopen.bmj.com · bmjopen.bmj.com
- Endoleak-induced DIC presenting as massive chest wall ... — casereports.bmj.com · casereports.bmj.com
- Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review — www.jacc.org · www.jacc.org
- LETTERS AND CORRECTIONS - Ovid — annals.org · annals.org
- Platelet Transfusion: A Clinical Practice Guideline From the AABB — annals.org · annals.org
- Disseminated Intravascular Coagulation Syndromes... : Obstetrics & Gynecology — journals.lww.com · journals.lww.com
- Clinical Expert Series : Obstetrics & Gynecology - Lippincott — journals.lww.com · journals.lww.com
- Sepsis‐induced disseminated intravascular coagulation — journals.lww.com · journals.lww.com
- Research trends and hotspots in sepsis-induced coagulopathy ... — journals.lww.com · journals.lww.com
- A re‐evaluation of the D‐dimer cut‐off value for making a diagnosis according to the ISTH overt‐DIC diagnostic criteria: communication from the SSC of the ISTH - Suzuki - 2018 - Journal of Thrombosis and Haemostasis - Wiley Online Library — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Disseminated Intravascular Coagulation - an overview | ScienceDirect Topics — www.sciencedirect.com · www.sciencedirect.com
- Global practice and challenges in the diagnosis and management of disseminated intravascular coagulation: communication from the ISTH SSC Subcommittee on Disseminated Intravascular Coagulation - ScienceDirect — www.sciencedirect.com · www.sciencedirect.com
- induced disseminated intravascular coagulation and coagulopathy — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- A stepwise laboratory-based approach for early risk assessment of disseminated intravascular coagulation - ScienceDirect — www.sciencedirect.com · www.sciencedirect.com
- The Japanese Clinical Practice Guidelines for Management of ... — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Diagnosis of sepsis‐induced disseminated intravascular ... — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Development of a model based scoring system for diagnosis of canine disseminated intravascular coagulation with independent assessment of sensitivity and specificity - ScienceDirect — www.sciencedirect.com · www.sciencedirect.com
- Disseminated Intravascular Coagulation (Chapter 355) — publications.aap.org · publications.aap.org
- Disseminated intravascular coagulation in pregnancy — www.ajog.org · www.ajog.org
- Anticoagulants for people hospitalised with COVID‐19: a rapid review - Flumignan, RLG - 2022 | Cochrane Library — www.cochranelibrary.com · www.cochranelibrary.com
- ยาต้านการแข็งตัวของเลือดสำหรับผู้ที่เข้ารับการรักษาในโรงพยาบาลด้วย ... — www.cochranelibrary.com · www.cochranelibrary.com
- Epidemiology and outcomes of disseminated intravascular ... — ascopubs.org · ascopubs.org
- Diagnosis of sepsis‐induced disseminated intravascular coagulation and coagulopathy - PMC — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov